RAPTOR PHARMACEUTICAL CORP's ticker is and the CUSIP is 75382F906. A total of 2 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $183,000 | +157.7% | 34,100 | +121.4% | 0.00% | – |
| Q1 2016 | $71,000 | -47.0% | 15,400 | -40.3% | 0.00% | – |
| Q4 2015 | $134,000 | -35.3% | 25,800 | -24.6% | 0.00% | – |
| Q3 2015 | $207,000 | +33.5% | 34,200 | +249.0% | 0.00% | – |
| Q2 2015 | $155,000 | +70.3% | 9,800 | +16.7% | 0.00% | – |
| Q1 2015 | $91,000 | -50.8% | 8,400 | -52.3% | 0.00% | – |
| Q4 2014 | $185,000 | -32.5% | 17,600 | -38.5% | 0.00% | – |
| Q3 2014 | $274,000 | -20.3% | 28,600 | -4.0% | 0.00% | – |
| Q2 2014 | $344,000 | +45.1% | 29,800 | +25.7% | 0.00% | – |
| Q1 2014 | $237,000 | -45.1% | 23,700 | -28.6% | 0.00% | -100.0% |
| Q4 2013 | $432,000 | +72.1% | 33,200 | +97.6% | 0.00% | – |
| Q3 2013 | $251,000 | -44.2% | 16,800 | -65.1% | 0.00% | -100.0% |
| Q2 2013 | $450,000 | – | 48,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 47,700 | $713,000 | 0.01% |
| Citadel Advisors | 16,800 | $251,000 | 0.00% |